PET scan tracer to find lung or pancreas radiation injury
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism, Injuries & trauma, Lungs & breathing clinical trials.
This Phase 2 study tests a special PET scan tracer to help doctors spot tissue damage after radiation treatment in people with certain lung or pancreatic cancers. The goal is to improve detection and planning around chemoradiation and surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older, and you can sign consent in writing
- You can’t have used tobacco in the last 6 months (for lung cancer)
- You need to have the specific cancer diagnosis the study is looking for (NSCLC stages I–III not suited for surgery, or confirmed PDAC)
- You must be able to undergo PET/MRI scanning and lie comfortably in the scanner
- You should not have certain metal/implant items (like pacemakers, some metal clips, or metallic tattoos)
- You must not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This study uses a new imaging tracer, called 68Ga-SorB, during a PET/CT scan to look at tumors. It may help doctors see cancer more clearly. The trial is for adults with certain types of solid tumors (such as melanoma, liver, lung, breast, pancreatic, ovarian, or bile duct cancer) who need a PET/CT scan as part of their care.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working for pancreatic cancer. It may help your doctor understand if your treatment is effective.
This study uses a special PET scan (a type of imaging) to look at tumors in people with pancreatic, lung, or bowel cancer. The scan uses a new tracer that may help doctors see cancer more clearly.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.